Literature DB >> 23329123

On collapsibility and confounding bias in Cox and Aalen regression models.

Torben Martinussen1, Stijn Vansteelandt.   

Abstract

We study the situation where it is of interest to estimate the effect of an exposure variable [Formula: see text] on a survival time response [Formula: see text] in the presence of confounding by measured variables [Formula: see text]. Quantifying the amount of confounding is complicated by the non-collapsibility or non-linearity of typical effect measures in survival analysis: survival analyses with or without adjustment for [Formula: see text] typically infer different effect estimands of a different magnitude, even when [Formula: see text] is not associated with the exposure, and henceforth not a confounder of the association between exposure and survival time. We show that, interestingly, the exposure coefficient indexing the Aalen additive hazards model is not subject to such non-collapsibility, unlike the corresponding coefficient indexing the Cox model, so that simple measures of the amount of confounding bias are obtainable for the Aalen hazards model, but not for the Cox model. We argue that various other desirable properties can be ascribed to the Aalen model as a result of this collapsibility. This work generalizes recent work by Janes et al. (Biostatistics 11:572-582, 2010).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23329123     DOI: 10.1007/s10985-013-9242-z

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  10 in total

1.  Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

Authors:  M A Hernán; B Brumback; J M Robins
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

2.  Attributable fraction functions for censored event times.

Authors:  Li Chen; D Y Lin; Donglin Zeng
Journal:  Biometrika       Date:  2010-05-28       Impact factor: 2.445

3.  Direct and indirect effects in a survival context.

Authors:  Theis Lange; Jørgen V Hansen
Journal:  Epidemiology       Date:  2011-07       Impact factor: 4.822

4.  On quantifying the magnitude of confounding.

Authors:  Holly Janes; Francesca Dominici; Scott Zeger
Journal:  Biostatistics       Date:  2010-03-04       Impact factor: 5.899

5.  Invited commentary: G-computation--lost in translation?

Authors:  Stijn Vansteelandt; Niels Keiding
Journal:  Am J Epidemiol       Date:  2011-03-16       Impact factor: 4.897

6.  A linear regression model for the analysis of life times.

Authors:  O O Aalen
Journal:  Stat Med       Date:  1989-08       Impact factor: 2.373

7.  Identifiability, exchangeability, and epidemiological confounding.

Authors:  S Greenland; J M Robins
Journal:  Int J Epidemiol       Date:  1986-09       Impact factor: 7.196

8.  Components of the crude risk ratio.

Authors:  O S Miettinen
Journal:  Am J Epidemiol       Date:  1972-08       Impact factor: 4.897

9.  Confounding: essence and detection.

Authors:  O S Miettinen; E F Cook
Journal:  Am J Epidemiol       Date:  1981-10       Impact factor: 4.897

10.  Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: a principled yet flexible approach.

Authors:  Anastasios A Tsiatis; Marie Davidian; Min Zhang; Xiaomin Lu
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

  10 in total
  23 in total

1.  Does Cox analysis of a randomized survival study yield a causal treatment effect?

Authors:  Odd O Aalen; Richard J Cook; Kjetil Røysland
Journal:  Lifetime Data Anal       Date:  2015-06-24       Impact factor: 1.588

2.  Prevalent cohort studies and unobserved heterogeneity.

Authors:  Niels Keiding; Katrine Lykke Albertsen; Helene Charlotte Rytgaard; Anne Lyngholm Sørensen
Journal:  Lifetime Data Anal       Date:  2019-07-03       Impact factor: 1.588

3.  Causal inference in randomized clinical trials.

Authors:  Cheng Zheng; Ran Dai; Robert Peter Gale; Mei-Jie Zhang
Journal:  Bone Marrow Transplant       Date:  2019-03-26       Impact factor: 5.483

4.  On adjustment for auxiliary covariates in additive hazard models for the analysis of randomized experiments.

Authors:  S Vansteelandt; T Martinussen; E Tchetgen Tchetgen
Journal:  Biometrika       Date:  2013-11-21       Impact factor: 2.445

5.  Causal effects of cardiovascular risk factors on onset of major age-related diseases: A time-to-event Mendelian randomization study.

Authors:  Liang He; Irina Culminskaya; Yury Loika; Konstantin G Arbeev; Olivia Bagley; Matt Duan; Anatoliy I Yashin; Alexander M Kulminski
Journal:  Exp Gerontol       Date:  2017-09-28       Impact factor: 4.032

6.  Instrumental variable estimation of complier causal treatment effect with interval-censored data.

Authors:  Shuwei Li; Limin Peng
Journal:  Biometrics       Date:  2021-09-16       Impact factor: 2.571

7.  Decreased risk of acute myocardial infarction in stroke patients receiving acupuncture treatment: a nationwide matched retrospective cohort study.

Authors:  Sun-Fa Chuang; Chun-Chuan Shih; Chun-Chieh Yeh; Hsin-Long Lane; Chin-Chuan Tsai; Ta-Liang Chen; Jaung-Geng Lin; Tainsong Chen; Chien-Chang Liao
Journal:  BMC Complement Altern Med       Date:  2015-09-09       Impact factor: 3.659

8.  Mechanisms and mediation in survival analysis: towards an integrated analytical framework.

Authors:  Jonathan Pratschke; Trutz Haase; Harry Comber; Linda Sharp; Marianna de Camargo Cancela; Howard Johnson
Journal:  BMC Med Res Methodol       Date:  2016-02-29       Impact factor: 4.615

9.  Estimation and modeling of the restricted mean time lost in the presence of competing risks.

Authors:  Sarah C Conner; Ludovic Trinquart
Journal:  Stat Med       Date:  2021-02-10       Impact factor: 2.373

10.  The effect of adherence to statin therapy on cardiovascular mortality: quantification of unmeasured bias using falsification end-points.

Authors:  Maarten J Bijlsma; Stijn Vansteelandt; Fanny Janssen; Eelko Hak
Journal:  BMC Public Health       Date:  2016-04-11       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.